Correlation Between Enliven Therapeutics and Nuvectis Pharma
Can any of the company-specific risk be diversified away by investing in both Enliven Therapeutics and Nuvectis Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enliven Therapeutics and Nuvectis Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enliven Therapeutics and Nuvectis Pharma, you can compare the effects of market volatilities on Enliven Therapeutics and Nuvectis Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enliven Therapeutics with a short position of Nuvectis Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enliven Therapeutics and Nuvectis Pharma.
Diversification Opportunities for Enliven Therapeutics and Nuvectis Pharma
0.72 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Enliven and Nuvectis is 0.72. Overlapping area represents the amount of risk that can be diversified away by holding Enliven Therapeutics and Nuvectis Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nuvectis Pharma and Enliven Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enliven Therapeutics are associated (or correlated) with Nuvectis Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nuvectis Pharma has no effect on the direction of Enliven Therapeutics i.e., Enliven Therapeutics and Nuvectis Pharma go up and down completely randomly.
Pair Corralation between Enliven Therapeutics and Nuvectis Pharma
Given the investment horizon of 90 days Enliven Therapeutics is expected to under-perform the Nuvectis Pharma. But the stock apears to be less risky and, when comparing its historical volatility, Enliven Therapeutics is 1.28 times less risky than Nuvectis Pharma. The stock trades about -0.09 of its potential returns per unit of risk. The Nuvectis Pharma is currently generating about 0.24 of returns per unit of risk over similar time horizon. If you would invest 458.00 in Nuvectis Pharma on October 23, 2024 and sell it today you would earn a total of 113.00 from holding Nuvectis Pharma or generate 24.67% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Enliven Therapeutics vs. Nuvectis Pharma
Performance |
| Timeline |
| Enliven Therapeutics |
| Nuvectis Pharma |
Enliven Therapeutics and Nuvectis Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Enliven Therapeutics and Nuvectis Pharma
The main advantage of trading using opposite Enliven Therapeutics and Nuvectis Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enliven Therapeutics position performs unexpectedly, Nuvectis Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nuvectis Pharma will offset losses from the drop in Nuvectis Pharma's long position.| Enliven Therapeutics vs. Pmv Pharmaceuticals | Enliven Therapeutics vs. Cullinan Oncology LLC | Enliven Therapeutics vs. Immuneering Corp | Enliven Therapeutics vs. Aerovate Therapeutics |
| Nuvectis Pharma vs. Replimune Group | Nuvectis Pharma vs. Lyra Therapeutics | Nuvectis Pharma vs. Kronos Bio | Nuvectis Pharma vs. Gossamer Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Complementary Tools
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |